58
Participants
Start Date
October 18, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2031
Vorasidenib
For oral administration once daily
Placebo
For oral administration once daily
RECRUITING
Tiantan Hospital, Beijing
RECRUITING
Huashan Hospital Fudan University, Shanghai
RECRUITING
The Second People's Hospital of Shenzhen, Shenzhen
RECRUITING
West China Hospital Sichuan University, Chengdu
NOT_YET_RECRUITING
Bejing Tsinghua Changgung Hospital, Beijing
NOT_YET_RECRUITING
Cancer Hospital Chinese Academy of Medical Science, Beijing
NOT_YET_RECRUITING
Peking Union Medical College Hospital, Beijing
RECRUITING
Sanbo Brain Hospital, Capital Medical University, Beijing
NOT_YET_RECRUITING
Xuanwu Hospital Capital Medial University, Beijing
NOT_YET_RECRUITING
The First Affilated Hospital of Fujian Medical University, Fuzhou
NOT_YET_RECRUITING
SUN Yat-Sen University Cancer Center, Guangzhou
NOT_YET_RECRUITING
Harbin Medical University Cancer Hospital, Harbin
NOT_YET_RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
The Second Affiliated Hospital of Air Force Military Medical University, Xi'an
NOT_YET_RECRUITING
The Affiliated Hospital of Xuzhou Medical Hospital, Xuzhou
NOT_YET_RECRUITING
Taipei Veterans General Hospital, Taipei
NOT_YET_RECRUITING
Chang Gung Memorial Hospital,, Taoyuan District
Servier
INDUSTRY